High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

April 25, 1997

Primary Completion Date

April 12, 2001

Study Completion Date

December 15, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

mitoxantrone hydrochloride

DRUG

tamoxifen citrate

Trial Locations (25)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

V5Z 4E6

BC Cancer Agency, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6ZB

Moncton Hospital, Moncton

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Newfoundland Cancer Treatment and Research Foundation, St. John's

B3H 1V7

Nova Scotia Cancer Centre, Halifax

L6W 2Z8

William Osler Health Centre, Brampton

P3E 5J1

Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

K1H 1C4

Ottawa Regional Cancer Centre - General Campus, Ottawa

L2R 5K3

Hotel Dieu Hospital - St. Catharines, St. Catharines

P7A 7T1

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

C1A 8T5

Queen Elizabeth Hospital, PEI, Charlottetown

G6V 3Z1

L'Hotel Dieu de Levis, Lévis

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

H2W 1S6

McGill University Department of Oncology, Montreal

H2W 1T8

Hotel Dieu de Montreal, Montreal

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Québec

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK